Yunu Provides Free Platform Access for Children's Oncology Group Clinical Trials
核心洞察
Yunu (搜索) is extending free use of its clinical trial imaging platform to all Children's Oncology Group (COG) clinical trials nationwide, aiming to improve pediatric cancer (搜索) care.
The initiative waives implementation and platform time-point fees for COG trials at collaborating sites with a Yunu (搜索) subscription, enhancing access to advanced imaging.
Yunu (搜索)'s platform reduces research coordinator time by 80% and radiologist time by 50% on imaging assessments, while also minimizing clinical trial imaging data error rates.
Yunu (搜索), a provider of clinical trial imaging workflow and data management technology, will extend free use of its platform for all Children’s Oncology Group (搜索) (COG) clinical trials nationwide. This initiative aims to provide pediatric cancer (搜索) hospitals access to imaging capabilities by waiving all Yunu implementation and platform time-point fees for COG trials at collaborating sites with a minimal Yunu subscription.
Improving Pediatric Cancer Care
The Children’s Oncology Group (搜索) (COG), a part of the National Cancer (搜索) Institute’s (NCI) National Clinical Trials Network (NCTN), comprises 10,000 researchers and 200 leading hospitals and cancer centers. COG focuses on conducting clinical trials to improve the prevention, diagnosis, and treatment of cancer in children and adolescents. Over 90% of the 16,000 children and adolescents diagnosed with cancer each year in the United States are cared for at COG member institutions.
Streamlining Clinical Trials
Yunu (搜索)'s platform currently supports active COG trials, reducing study start-up time for trial teams. The Children’s Oncology Group (搜索) has nearly 100 active clinical trials open at any given time, including front-line treatment trials, studies on the underlying biology of childhood cancers, and trials involving new treatments, supportive care, and survivorship. All protocols for these trials are readily accessible to users on day one of their platform subscription.
Enhancing Efficiency and Accuracy
Beyond start-up savings, the Yunu (搜索) platform reduces research coordinator time by 80% and radiologist time by 50% on every trial imaging assessment. Clinical trial imaging data often has error rates of 25-50%, even at leading cancer (搜索) centers. Yunu aims to transform trial efficiency and accuracy, ensuring audit readiness and reducing these error rates to near zero.
Commitment to Pediatric Cancer
Yunu (搜索) is dedicated to extending trial imaging excellence to all pediatric cancer (搜索) hospitals, especially those serving underserved and rare pediatric disease populations. The company’s support of Children’s Oncology Group (搜索)’s cooperative trials is based on their efforts in pediatric research. Yunu aims to ensure clinicians have accurate, timely, and accessible imaging data to inform treatment and care decisions, improving the chances of survival for children facing cancer.
About Yunu
Yunu (搜索) provides medical research technology and services to life sciences companies and clinical research environments that perform precision imaging assessments. Yunu aims to ensure breakthrough therapies are accessible to everyone by unifying medical imaging insights and connecting clinical communities. With thousands of clinical trials relying on the platform daily, Yunu is delivering a new standard for clinical trial imaging workflow.